Introduction
Hopes of preventing childhood obesity rely not only on effective interventions, but also on the early identification of those children who are at highest risk of becoming overweight or obese. Several studies have recently reported that rapid weight gain during early postnatal life predicts subsequent increased obesity risk during later childhood, and this risk persists in young adults (1) (2) (3) (4) . We hypothesised that childhood adiposity relates to both genetic factors and rate of early postnatal weight gain.
We recently reported confirmation of association between the insulin gene (INS) variable number of tandem repeat (VNTR) polymorphism and size at birth in the Avon Longitudinal Study of Parents and Children (ALSPAC), both by repeated association in a 2 nd ALSPAC sub-group, and by demonstrating association with parental transmitted alleles (5) . The class III alleles were recessively associated with larger head circumference at birth, higher cord blood levels of insulin-like growth factor-2, and those associations showed significant interaction with birth order and postnatal rapid weight gain, a marker of previous intra-uterine growth restriction.
In that study of normal representative UK children, we also observed that class III/III children had greater body weight, BMI and waist circumference at age 8 years;
however those postnatal associations appeared to be reversed among the 25% of children who showed early postnatal rapid weight gain (5) . Similarly, among obese
French children the INS VNTR class I alleles, rather than the class III, were associated with increased BMI gains (6) . A further study in obese children reported that the INS VNTR was a quantitative trait locus for the insulin response to oral glucose, and those authors hypothesised that class I alleles could confer greater insulin secretion for the degree of BMI compared to class III alleles (7).
We have now reanalysed our existing INS VNTR genotype data in the ALSPAC children with new phenotype data on body composition at age 9 years, in order to distinguish between genetic associations with fat mass or lean mass. We also aimed to confirm the reported interactive effects of INS VNTR genotype and BMI on insulin secretion.
Methods

Subjects
As part of the ALSPAC study, previously described (8), the "Children in Focus" and "Control" sub-cohorts were measured at age 3 years, in addition to the whole ALSPAC cohort measurements at birth, 7 years and 9 years, when all children also had a whole body dual X-ray emission absorptiometry (DXA) scan. Analysis of body composition at age 9 years was based on 947 children with full data on DXA parameters, early growth phenotypes and INS VNTR genotype. Analysis of insulin secretion at age 8 years was based on 750 children with complete data. The subjects analysed in this paper did not differ from the whole ALSPAC cohort with respect to childhood growth at age 9 years (data provided to reviewers). Preparation of DNA and genotyping for INS VNTR were previously described (5).
Body composition
At age 9.9 (+/-0.33) years all ALSPAC children were invited to attend for a 3-hour hands-on assessment. Height was measured with shoes and socks removed using a Following oral glucose there is a dose-response relationship between glucose and insulin (12) , and this correction for the attained glucose level has been shown to correlate most closely with the first-phase insulin response (13) . Similar results were found when insulin secretion was estimated using the insulinogenic index (insulin30 -insulin0) / (glucose30 -glucose0) (14) .
Statistical analysis
All data were explored for normality of distribution and log transformed where appropriate. The association between genotype and phenotype was analysed using a linear regression model under both global and recessive models.
For the association with DXA, adjustment was performed on age, gender, parity, education level of the mother and change in weight between birth and 3 years.
Interaction between genotype and postnatal weight gain was examined by introducing and testing the interactive term (genotype weight gain) in the previous models.
Adjusted regression coefficients are shown separately for each genotype group.
The association between genotype and insulin secretion at 8 years was examined adjusting for age, gender and BMI at 8 years. The interaction effect between BMI and genotype was analysed introducing and testing the interactive term (genotype BMI).
Analyses were performed using SPSS for Windows version 11.0 (SPSS, Chicago, IL).
Results
Mean body size and body composition at age 9 years are displayed by genotype in Table 1 . Overall, homozygous III/III children had larger body weight, BMI, fat mass index and truncal fat mass index at age 9 years than class I bearers (p=0.01 to 0.02), but there was no difference in fat-free mass ( Table 1) .
Rate of early postnatal weight gain between birth to 3 years was positively associated with BMI at age 9 years in class I/I and I/III children (p<0.0001), but not in III/III children (p=0.74); and the difference in regression slopes between class I bearers and homozygous III/III children was significant, (p-interaction with genotype=0.009; Table 2 , Figure 1 ). Similarly, rate of weight gain between birth to 3 years was positively associated with fat mass index at age 9 years in class I bearers (p<0.0001),
but not in III/III children (p=0.68), (p-interaction=0.064; Table 2 ).
Mean fasting insulin levels, insulin sensitivity and parameters of insulin secretion at age 8 years are displayed by genotype in Table 3 
Discussion
In this representative cohort of UK children the INS VNTR class III/III genotype was associated with increased childhood body fat mass in the overall population. These results do not represent independent confirmation of our previous reported association between INS VNTR with BMI at age 8 years in this same group of subjects (5), however they clarify that the association is with body fat mass rather than lean mass.
Furthermore, we provide significant confirmation of two recently reported genetic interactions, which many go some way towards explaining the different INS VNTR genotype associations seen in different childhood sub-groups. First, as we previously observed (5), the III/III genotype association with larger size was particularly seen among those children who did not gain weight rapidly during infancy. In contrast, with increasing rate of early postnatal weight gain class I bearers, but not III/III genotype children, had larger BMI and fat mass at age 9 years. Secondly, similar to another previous study (7), we found that in class I bearers insulin secretion increased significantly more rapidly with increasing BMI compared to class III/III children.
In childhood populations obesity risk has been variably associated with either class III or class I INS VNTR alleles. Among children with early onset obesity those with the class I allele had greater BMI gains (6), and class I allele have been associated with overweight in a further French childhood growth study (15) ; in contrast in another study of non-obese girls the III/III homozygotes had greater fat mass by DXA (16) .
Recent adult population studies the INS VNTR showed no overall association with obesity risk (17, 18) . Our findings of genetic interaction with early postnatal weight gain on subsequent BMI and body composition could provide a possible explanation for these contrasting reports. Our findings could suggest two separate pathways to later obesity risk: rapid infant weight gain associated with the INS VNTR class I allele, and non-rapid infant weight gain associated with the III/III genotype. Genetic association studies for obesity should consider such potential interactions with early postnatal weight gain.
A further complexity is that effects of INS VNTR alleles may differ according to parent-of origin (19) . Among French children with early onset obesity, those who inherited a class I allele from their father (but not from their mother) had a 1.8-fold increased risk of obesity (20) . Our studies in this ALSPAC sub-cohort do not have sufficient power to explore parent-of-origin effects (5) . Selection of children with extreme early-onset obesity would also provide much greater power to detect the class I association with obesity, however population-based studies are more generalisable Thus, it is possible that the class I allele, could confer a greater responsiveness in insulin secretion to changes in BMI and insulin sensitivity, and therefore a predisposition to storing adipose rather than lean tissue during periods of rapid weight gain, or in obese children (6) . This could predispose to future type 2 diabetes, in particular related to the development of insulin resistance. Conversely, relatively lower insulin secretion in class III/III subjects in the face of increasing BMI or insulin resistance could also contribute to increased type 2 diabetes risk (34) . Recent large studies in adults have shown no overall influence of INS VNTR genotype on type 2 diabetes risk (35) . However, similar to obesity risk, we hypothesise that the pathogenesis and phenotype of type 2 diabetes could differ according to both early weight gain patterns and INS VNTR genotype.
In conclusion, in these representative children the INS VNTR class III/III genotype was overall associated with increased adiposity. However significant genetic interactions were seen with BMI and insulin secretion that could also support a class I allele predisposition to obesity following rapid infant weight gain. Different INS VNTR genotypes and patterns of early postnatal weight gain could underlie discrete developmental pathways to obesity and type 2 diabetes risks.
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